Medical Condition News

RSS

RAS-MAPK inhibition halts spinal deformity in neurofibromatosis type 1 mouse model

Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people.

14 Jan 2026

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden.

14 Jan 2026

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab.

14 Jan 2026

New BIND screener identifies brain-related comorbidities risk in Duchenne muscular dystrophy

In research published in Developmental Medicine & Child Neurology, investigators developed a brief, reliable, and valid screening tool to help identify individuals with Duchenne muscular dystrophy (a neuromuscular disorder) who are at increased risk of brain-related comorbidities, such as language disorders, attention-deficit/hyperactivity disorder, and anxiety.

14 Jan 2026

Long-term singles experience sharper decline in life satisfaction and well-being

More and more young adults abstain from entering committed romantic relationships, and this may be affecting their well-being.

14 Jan 2026

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

January is Glaucoma Awareness Month, prompting Rutgers Health experts to underscore the importance of early detection and public awareness.

14 Jan 2026

Cannabidiol could become a therapeutic tool for fetal alcohol spectrum disorder

Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal alcohol spectrum disorder (FASD), a condition caused by alcohol exposure during pregnancy.

14 Jan 2026

DTU researchers discover gut bacteria link to reduced allergy and asthma risk

Researchers from DTU have patented an invention that uses naturally produced substances from gut bacteria of the bifidobacteria type to reduce the risk of allergies and asthma.

14 Jan 2026

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Diabetes, a metabolic disease, is on the rise worldwide, and over 90 percent of cases are type 2 diabetes, where the body does not effectively respond to insulin.

14 Jan 2026

Vaccines are helping older people more than we knew

Let's be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in their lifetimes, one that can cause lingering nerve pain and other nasty long-term consequences.

14 Jan 2026

Bariatric surgery reshapes body fat and muscle more than GLP-1 drugs

Bariatric surgery and GLP-1 treatments reshape body composition differently, emphasizing the importance of sex and treatment choice in muscle preservation.

14 Jan 2026

Specific foods linked to autism risk via immune pathways

Genetic and clinical data suggest dietary factors may influence autism risk via immune pathways, highlighting the need for further research in this area.

14 Jan 2026

Light daily movement linked to longer life in cardiometabolic disease

Researchers determine the impact of light physical activity on mortality in people with cardiovascular-kidney-metabolic syndrome.

14 Jan 2026

New mouse model enables study of chronic lung infections in aging

Respiratory infections are among the leading causes of illness and death in the elderly, driven by immune aging, chronic diseases, and reduced physiological resilience.

13 Jan 2026

New European initiative aims to transform real world Alzheimer’s disease care

Today, the ACCESS-AD consortium is announcing the launch of a transformative European initiative that will accelerate the implementation of scientific innovations for Alzheimer's disease (AD) management in real-world health systems.

13 Jan 2026

Study explores how biological and environmental systems regulate body weight

Pennington Biomedical researchers recently investigated the systems of the body that regulate weight, exploring whether our bodies defend an established weight target or if our bodies operate within a broader range of tolerance before biological mechanisms are activated.

13 Jan 2026

Novel antibody shows promise in overcoming resistance to cancer immunotherapy

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the potential to overcome treatment resistance to anti-PD-1 immune checkpoint inhibitors in multiple cancer types.

13 Jan 2026

Preclinical study reveals potential new treatment for severe liver fibrosis

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis - a dangerous, disease-induced build-up of scar tissue in the liver that often leads to cancer.

13 Jan 2026

Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial.

13 Jan 2026

Implanted vagus nerve stimulation device offers lasting relief for severe depression

About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few treatment attempts, but up to one-third of patients have treatment-resistant depression, for which standard antidepressant medication or psychotherapy isn't enough.

13 Jan 2026

Medical Condition News

RAS-MAPK inhibition halts spinal deformity in neurofibromatosis type 1 mouse model

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

New BIND screener identifies brain-related comorbidities risk in Duchenne muscular dystrophy

Long-term singles experience sharper decline in life satisfaction and well-being

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

Cannabidiol could become a therapeutic tool for fetal alcohol spectrum disorder

DTU researchers discover gut bacteria link to reduced allergy and asthma risk

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Vaccines are helping older people more than we knew

Bariatric surgery reshapes body fat and muscle more than GLP-1 drugs

Specific foods linked to autism risk via immune pathways

Light daily movement linked to longer life in cardiometabolic disease

New mouse model enables study of chronic lung infections in aging

New European initiative aims to transform real world Alzheimer’s disease care

Study explores how biological and environmental systems regulate body weight

Novel antibody shows promise in overcoming resistance to cancer immunotherapy

Preclinical study reveals potential new treatment for severe liver fibrosis

Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial

Implanted vagus nerve stimulation device offers lasting relief for severe depression

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News